A phase II dose evaluation pilot feasibility randomized controlled trial of cholecalciferol in critically ill children with vitamin D deficiency (VITdAL-PICU study).

MLA

O’Hearn, Katie, et al. “A Phase II Dose Evaluation Pilot Feasibility Randomized Controlled Trial of Cholecalciferol in Critically Ill Children with Vitamin D Deficiency (VITdAL-PICU Study).” BMC Pediatrics, vol. 23, no. 1, July 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s12887-023-04205-9.

APA

O’Hearn, K., Menon, K., Weiler, H. A., Amrein, K., Fergusson, D., Gunz, A., Bustos, R., Campos, R., Catalan, V., Roedl, S., Tsampalieros, A., Barrowman, N., Geier, P., Henderson, M., Khamessan, A., Lawson, M. L., McIntyre, L., Redpath, S., Jones, G., & Kaufmann, M. (2023). A phase II dose evaluation pilot feasibility randomized controlled trial of cholecalciferol in critically ill children with vitamin D deficiency (VITdAL-PICU study). BMC Pediatrics, 23(1), 1–16. https://doi.org/10.1186/s12887-023-04205-9

Chicago

O’Hearn, Katie, Kusum Menon, Hope A. Weiler, Karin Amrein, Dean Fergusson, Anna Gunz, Raul Bustos, et al. 2023. “A Phase II Dose Evaluation Pilot Feasibility Randomized Controlled Trial of Cholecalciferol in Critically Ill Children with Vitamin D Deficiency (VITdAL-PICU Study).” BMC Pediatrics 23 (1): 1–16. doi:10.1186/s12887-023-04205-9.